Cyclerion Therapeutics, Inc. (CYCN)

Cyclerion Therapeutics Statistics

Total Valuation

CYCN has a market cap or net worth of $6.01 million. The enterprise value is $1.37 million.

Market Cap	6.01M
Enterprise Value	1.37M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CYCN has 3.81 million shares outstanding. The number of shares has increased by 14.72% in one year.

Current Share Class	3.81M
Shares Outstanding	3.81M
Shares Change (YoY)	+14.72%
Shares Change (QoQ)	+5.01%
Owned by Insiders (%)	19.33%
Owned by Institutions (%)	19.63%
Float	3.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.52
Forward PS	n/a
PB Ratio	0.59
P/TBV Ratio	0.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.78

Current Ratio	5.78
Quick Ratio	5.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.80% and return on invested capital (ROIC) is -25.60%.

Return on Equity (ROE)	-24.80%
Return on Assets (ROA)	-23.51%
Return on Invested Capital (ROIC)	-25.60%
Return on Capital Employed (ROCE)	-38.09%
Revenue Per Employee	$2.86M
Profits Per Employee	-$2.20M
Employee Count	1
Asset Turnover	0.30
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.93% in the last 52 weeks. The beta is 0.93, so CYCN's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-25.93%
50-Day Moving Average	2.05
200-Day Moving Average	2.63
Relative Strength Index (RSI)	43.09
Average Volume (20 Days)	1,056,584

Short Selling Information

The latest short interest is 102,981, so 2.71% of the outstanding shares have been sold short.

Short Interest	102,981
Short Previous Month	109,908
Short % of Shares Out	2.71%
Short % of Float	3.35%
Short Ratio (days to cover)	1.63

Income Statement

In the last 12 months, CYCN had revenue of $2.86 million and -$2.20 million in losses. Loss per share was -$0.77.

Revenue	2.86M
Gross Profit	2.65M
Operating Income	-3.63M
Pretax Income	-2.20M
Net Income	-2.20M
EBITDA	n/a
EBIT	-3.63M
Loss Per Share	-$0.77

Balance Sheet

The company has $4.57 million in cash and n/a in debt, giving a net cash position of $4.57 million or $1.20 per share.

Cash & Cash Equivalents	4.57M
Total Debt	n/a
Net Cash	4.57M
Net Cash Per Share	$1.20
Equity (Book Value)	9.54M
Book Value Per Share	2.58
Working Capital	4.19M

Cash Flow

Operating Cash Flow	-1.38M
Capital Expenditures	n/a
Free Cash Flow	-1.38M
FCF Per Share	-$0.36

Margins

Gross margin is 92.64%, with operating and profit margins of -127.25% and -77.02%.

Gross Margin	92.64%
Operating Margin	-127.25%
Pretax Margin	-77.02%
Profit Margin	-77.02%
EBITDA Margin	n/a
EBIT Margin	-127.25%
FCF Margin	n/a

Dividends & Yields

CYCN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.72%
Shareholder Yield	-14.72%
Earnings Yield	-37.03%
FCF Yield	-23.16%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 16, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	May 16, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

CYCN has an Altman Z-Score of -31.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-31.2
Piotroski F-Score	3